Possible entry at market approx @22.90
Target price $25.66
Stop loss $21.94
Drugmaker Moderna Inc. has shipped the first batch of its rapidly developed coronavirus vaccine to U.S. government researchers, who will launch the first human tests of whether the experimental shot could help suppress the epidemic originating in China. Source Wall street Journal
Moderna has an analyst consensus of Strong Buy, with a price target consensus of $31.20, implying a 62.2% upside from current levels. In a report issued on February 17, Oppenheimer also maintained a Buy rating on the stock with a $31.00 price target. Source smarter analyst